期刊文献+

山楂叶HPLC指纹图谱研究 被引量:17

HPLC fingerprint chromatogram of leaves of Hawthorn
在线阅读 下载PDF
导出
摘要 目的:建立山楂属植物叶的HPLC指纹图谱,对该属植物中所含的化学成分进行综合评价,并为该属植物叶鉴定提供依据。方法:对10个产地山楂叶进行分析,以绿原酸为内参照物,检测它们所含牡荆素,金丝桃苷,牡荆素鼠李糖苷,芦丁,鼠李糖芦丁,槲皮素,葡萄糖牡荆素的含量。结果:不同种山楂叶均显示了它们各自的指纹特征。结论:HPLC指纹谱可以用来鉴别山楂属的不同种植物叶,该属植物种间的化学成分差别较大,而且主要特征性成分的含量也存在明显差异。 AIM: To establish HPLC fingerprint chromatogram of leaves of Hawthorn and to evaluate the con- stituents and to provide the basis for identification. METHODS: Leaves of Hawthorn come from 10 production places were analysed to gain its contents, such as Vitexin, Hyperoside, 2"-O-Rhamnosylvitexin, Rutin, 4"-O-Rham- nosylrutin, Chlorogenic acid, Quercetin 3-O-13-glucoside ,4"-O-Glucosylvitexiu, and internal reference selected Chlorogenic acid. RESULTS: The different leaves of Hawthorn showed different HPLC chromatogram. CONCLUSION: HPLC chromatogram can be used to distinguish the leaves of different species of Hawthorn and the content of the main characteristic components are various as production places vary.
出处 《中成药》 CAS CSCD 北大核心 2007年第1期7-11,共5页 Chinese Traditional Patent Medicine
基金 国家自然科学基金资助项目(No.30472161)
关键词 山楂叶 HPLC 指纹图谱 Hawthorn leaves HPLC fingerprint chromatogram
  • 相关文献

参考文献13

  • 1Mabberley D J.The plant-book:a portable dictionary of the vascular plants[M].2nd ed.Cambridge,UK:Cambridge University Press,1997.858.
  • 2Phipps JB.Biogeographic,taxonomic,and cladistic relationships between east asiatic and North American Crataegus[J].Annals Missouri Bot Gard,1983,70:667-700.
  • 3Christensen KI.Revision of Crataegus Sect.Crataegus and Nothosect.Crataeguineae (Rosaceae B Maloideae) in the Old World[M].Syst Bot Monogr,1992,35:1-199.
  • 4Phipps JB,Robertson KR,Smith PG,et al.A checklist of the subfamily Maloideae (Rosaceae)[J].Can J Bot,1990,68:2209-2269.
  • 5Chang Q,Zuo Z,Harrison F,et al.Hawthorn[J].J Clin Pharmacol,2002,42(6):605-612.
  • 6许正斌 高奎斌 许双贵.山楂叶综述[J].特产科学实验,1987,(1):29-31.
  • 7Rigelsky J M,Sweet BV.Hawthorn:pharmacology and therapeutic uses[J].Am J Health Syst Pharm,2002,59 (5):417-422.
  • 8Tauchert M,Gilder A,Lipinski J.High-dose Crataegus extract WS 1442 in the treatment of NYHA stage H heart failure[J].Herz,1999,24(6):465-474.
  • 9Christian J F,Holubarsch,Wilson S C.Thomas M,et al.Survival and Prognosis:Investigation of Crataegus Extract WS 1442 in congestive heart failure SPICE rationale,study design and study protocol[J].Eur J Heart Failure,2000,2:431-437.
  • 10Tauchert M.Efficacy and safety of crataegus extract WS 1442 in comparison with placebo in patients with chronic stable New York Heart Association class-Ⅲ heart failure[J].Am Heart J,2002,143(5):910-915.

共引文献15

同被引文献243

引证文献17

二级引证文献126

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部